Healthy outlook on life!
MEDIPAL is a modern, high-performance distribution company. It is amongst Top 10 pharmaceutical leading suppliers under government contracts in the Russian Federation.
Learn more
TOP 10
ranking among
>25 years
of successful operation
14 offices
and representative offices
> 250
partners in the pharmaceutical industry- Mission
- Corporate Values
- History
- Social Responsibility
- Business Ethics
Draw on experience and knowledge to be the best at everything and stay on target. To unite and inspire a team of like-minded people constantly moving forward. To develop our success by acting responsibly, innovating, and improving the quality of life and the health of people.
Everything we do is based on the corporate values that we defined for ourselves as a priority at the very beginning of our activity: responsibility, development, humanity, success.
For more than 25 years MEDIPAL has been a successful company demonstrating steady growth, social responsibility and confident development prospects.
Charitable activities are an integral part of the company’s overall strategy. For many years we have been active participants in various social programs and initiatives.
Corporate reputation is one of the keys to business success. We are convinced that in addition to complying with all laws and regulations, it is important to act in accordance with the highest ethical and moral standards.
On June 15-16 of this year, the First International Pharmaceutical Forum was held in Tashkent, organized by the Ministry of Investments and Foreign Trade of the Republic of Uzbekistan, the Agency for the Development of the Pharmaceutical Industry, as well as the Association of Representative Offices of Foreign Pharmaceutical Companies and Manufacturers in the Republic of Uzbekistan.
On April 14-15, the conference "Diagnosis and treatment of tumors of thoracoabdominal localization" was held in Moscow, in which MEDIPAL Group took part.
The meeting was very productive, eventful, and informative. The company guided the “ASTOM” representatives through the complete technological chain of production — from the beginning of the assembly of products on a modern robotic line to the release of products in finished packaging.
Since the beginning of 2022, Gemamed, a resident company of the Technopolis Moscow Special Economic Zone (SEZ), has supplied more than 810,000 medical devices for ostomy patients, who receive these goods from the city free of charge, as part of an offset agreement. This was reported by the press service of the Complex for Economic Policy and Property and Land Relations of the capital.
The journal “ASTOM: Guide to Active Life” published an article on GemaTech, a company involved in the production of stoma care products.
GemaTech took part in the RIA Novosti special project on public-private partnership in the Offset Agreement section.
Sergey Sobyanin held a meeting with representatives of major pharmaceutical companies where they discussed the development of the industry and import substitution in conditions of external sanctions pressure.
The government has approved the rules for the import into and export from the Russian Federation of biomaterials obtained during clinical trials of medicines for human use. They will come into force on September 1 and will be valid until September 1, 2028; a corresponding decree of the Russian government has been published on the official Internet portal of legal information.
Careers
Our success is determined by our team — a team of caring people who share common values
Many years ago we chose health care as our mission and over the years of our development we have become a large professional company, earned a reputation of a reliable partner and gained a leading position in the industry. Today we are looking into the future with confidence.
Partners
Our partners include more than 250 leading Russian and foreign manufacturers of medicines and medical products.
